CG Oncology, Inc. (CGON) Net margin 2023–2025
CG Oncology, Inc. (CGON) net profit margin by fiscal year — reported net income divided by reported revenue.
-3985.0%FY2025 · since FY2023: -23827.0% → -3985.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -3985.0% | +3744.5 pp |
| FY2024 | -7729.5% | +16097.5 pp |
| FY2023 | -23827.0% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CGON financial trends
CGON RevenueCGON Net incomeCGON Gross profitCGON Gross marginCGON Operating incomeCGON Operating marginCGON Operating cash flowCGON Free cash flowCGON Capital expendituresCGON Return on equityCGON Stock buybacksCGON Dividends paidCGON Total assetsCGON Total liabilitiesCGON Shareholders’ equityCGON overview →